PET/CT Emerging as Valuable Tool for Planning and Monitoring Cancer Treatment

Terri Bresenham, vice president for molecular imaging at GE Healthcare, discusses a trend in using molecular imaging technology to monitor cancer treatment, leading to better care and an improved patient experience. #GEHealthcare #GeneralElectric

Subscribe to GE Healthcare: https://invent.ge/3ipZ7wI

Learn more about GE Healthcare
Website: http://www.gehealthcare.com
Facebook: https://www.facebook.com/GEHealthcare
Twitter: http://twitter.com/gehealthcare
LinkedIn: http://www.linkedin.com/company/gehealthcare

About GE Healthcare:
As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

We embrace a culture of respect, transparency, integrity and diversity.

PET/CT Emerging as Valuable Tool for Planning and Monitoring Cancer Treatment | GE Healthcare
http://www.youtube.com/gehealthcare

source